AtriCure (ATRC) Tops Q4 EPS by 13c
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $31.79 +6.93%
EPS Growth %: +92.3%
Financial Fact:
Selling, general and administrative expenses: 25.49M
Today's EPS Names:
CRMT, More
EPS Growth %: +92.3%
Financial Fact:
Selling, general and administrative expenses: 25.49M
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
AtriCure (NASDAQ: ATRC) reported Q4 EPS of ($0.08), $0.13 better than the analyst estimate of ($0.21). Revenue for the quarter came in at $46.1 million versus the consensus estimate of $45.36 million.
2018 Financial Guidance
Management projects 2018 revenue of approximately $190 million to $196 million. Adjusted EBITDA, a non-GAAP measure, is projected to be positive for 2018.
For earnings history and earnings-related data on AtriCure (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- Freedom Broker Starts Unity Bancorp (UNTY) at Hold
- Pembina joins proposed 1M bbl/day Alberta-to-coast pipeline plan
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
